Company Filing History:
Years Active: 1993
Title: Richard L Mitchell: Innovator in Vascular Endothelial Cell Growth Factor
Introduction
Richard L Mitchell is a notable inventor based in Sunnyvale, CA. He has made significant contributions to the field of biotechnology, particularly in the development of vascular endothelial cell growth factors. With a total of 2 patents, his work has implications for medical treatments that require neovascularization or reendothelialization.
Latest Patents
Mitchell's latest patents include DNA sequences encoding bVEGF120 and hVEGF121. These patents describe isolated DNA sequences, expression vectors, and transformant cells that facilitate the large-scale production of vascular endothelial cell growth factor. This growth factor is essential for treating wounds that require healing through neovascularization or reendothelialization. The patents specifically highlight isolated vascular endothelial cell growth factors derived from bovine and human sources, which are crucial for effective wound treatment.
Career Highlights
Throughout his career, Richard L Mitchell has worked with various companies, including California Biotechnology Inc. and Scios Nova, Inc. His expertise in biotechnology has allowed him to contribute to advancements in medical treatments and therapies.
Collaborations
Some of his notable coworkers include Edmund G Tischer and Judith A Abraham. Their collaborative efforts have furthered research and development in the field of vascular biology.
Conclusion
Richard L Mitchell's innovative work in vascular endothelial cell growth factors has paved the way for advancements in wound healing therapies. His contributions continue to impact the field of biotechnology positively.